VC  Targeted Technology Fund

http://targetedtech.com/





     Office Locations:

18618 Tuscany Stone, Suite 100
San Antonio, TX 78258
Phone: 210-558-8896
Fax: 210-694-9466

 

Stages:

  • Early


 

Industries:

  • Medical Device

  •  

    Description:

    Managed by Incyte Venture Partners, the Targeted Technology Fund is a San Antonio-based venture capital fund formed to capitalize on the growth of the biomedical device sector in Texas, Alabama, Colorado and Georgia and the rapidly expanding investment opportunities in these regions. One of the significant investors in the fund is the Texas Research & Technology Foundation, which is comprised of multiple organizations whose work involves various stages of the very complicated drug development process. Graham Weston, Chairman of the Board of Rackspace; Bruce Barshop, a founder of Barshop Ventures LLC; and David Spencer, who is president of Texas Intrepid Ventures, a San Antonio-based investment firm, are also included in the pool of individual investors. The $12 million fund, which closed in 2009, will likely make up to 10 investments.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Alan Dean Senior Managing Partner
    Gary Frashier Managing Partner
    Ian Clements Managing Partner
    Jim Traa Managing Partner
    Paul Castella Senior Managing Partner

     

    Portfolio companies include:


      Aerin Medical
        web link


      BioDtech
        web link


      Bluegrass Vascular Technologies
        web link


      DNAtriX
        web link


      ENTrigue Surgical
        web link


      Innovative Trauma Care
        web link


      MimOSA Medical
        web link


      Santalis Pharmaceuticals
        web link


      Soluble Therapeutics
        web link


      VidaCare
        web link


      VirOxis
        web link


      Xenex
        web link


     

    Recent News:


      There is no recent news for Targeted Technology Fund.